Soligenix Stockholders Approve Reverse Split and 67% Increase in Authorized Shares

summarizeSummary

Soligenix stockholders approved a reverse stock split and a 67% increase in authorized shares, giving the board tools to maintain Nasdaq listing and continue ATM-driven financing.

check_boxKey Events · Corporate Governance and Compliance · SNGX

• Reverse Stock Split Approved

  Stockholders approved a reverse split at a ratio of 1-for-2 to 1-for-20, with the board authorized to determine the exact ratio and timing within one year.

• Authorized Shares Increased 67%

  Authorized common shares increased from 75,000,000 to 125,000,000, effective September 17, 2026, providing headroom for future equity issuance.

• ATM Program Update

  The company previously sold approximately $6,234,000 under the ATM Sales Agreement; the current prospectus supplement adds $2,500,000 in capacity.

• Nasdaq Listing Risk

  The reverse split is intended to maintain Nasdaq listing compliance, addressing the delisting risk previously disclosed in the Q2 2026 10-Q.

auto_awesomeAnalysis · SNGX · Life Sciences

Soligenix stockholders approved a reverse stock split at a ratio of 1-for-2 to 1-for-20 and a 67% increase in authorized common shares from 75 million to 125 million. The reverse split is designed to maintain Nasdaq listing compliance, while the authorized share increase provides headroom for continued ATM sales and potential future financing. The company has already sold approximately $6.2 million of shares under its ATM program, and the board now has discretion to execute the reverse split within one year.